Virtu Financial LLC Fsd Pharma Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.78 - $1.1 $31,646 - $44,629	-40,572 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.82 - $1.1 $18,220 - $24,442	-22,220 Reduced 35.39%	40,572 $35,000
Q4 2021 Feb 17, 2022	BUY	$0.96 - $1.63 $60,280 - $102,350	62,792 New	62,792 $65,000
Q3 2021 Nov 12, 2021	SELL	$1.45 - $1.84 $24,312 - $30,851	-16,767 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$1.56 - $2.13 $26,156 - $35,713	16,767 New	16,767 $29,000
Q4 2020 Feb 24, 2021	SELL	$1.36 - $2.7 $14,292 - $28,374	-10,509 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$2.55 - $4.26 $26,797 - $44,768	10,509 New	10,509 $27,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $146M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.